Antigen concentration, viral load, and test performance for SARS-CoV-2 in multiple specimen types

The relationship between N-antigen concentration and viral load within a specimen and across different specimens is essential for interpretation of rapid diagnostic tests (RDT) clinical performance in different use cases. A prospective study was conducted in Porto Velho, Brazil, to investigate RDT performance in different specimen types as a function of the correlation between antigen concentration and viral load. The study included 214 close contacts with recent exposures to confirmed cases, aged 12 years and older and with various levels of vaccination. Antigen concentration was measured in nasopharyngeal swab (NPS), anterior nares swab (ANS), and saliva specimens. Reverse transcriptase (RT)PCR was conducted on the NPS and saliva specimens, and two RDTs were conducted on ANS and one on saliva. Antigen concentration correlated with viral load when measured in the same specimen type but not across specimen types. Antigen levels were higher in symptomatic cases compared to asymptomatic/oligosymptomatic cases and lower in saliva compared to NPS and ANS samples. Discordant results between the RDTs conducted on ANS and the RT-PCR on NPS were resolved by antigen concentration values. The analytical limit-of-detection of RDTs can be used to predict the performance of the tests in populations for which the antigen concentration is known. The antigen dynamics across different sample types observed in SARS-CoV-2 disease progression support use of RDTs in nasal samples. Given lower antigen concentrations in saliva, tests using saliva is expected to require improved analytical sensitivity to achieve clinical sensitivity similar to testing of nasal samples.

[1]  Hannah C. Slater,et al.  A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19 , 2022, medRxiv.

[2]  N. Hulo,et al.  Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 , 2022, Nature Medicine.

[3]  K. McPhaul,et al.  Comparison of Saliva and Midturbinate Swabs for Detection of SARS-CoV-2 , 2022, Microbiology spectrum.

[4]  D. Dean,et al.  SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva , 2022, medRxiv.

[5]  Hannah C. Slater,et al.  Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations , 2022, medRxiv.

[6]  P. Drain Rapid Diagnostic Testing for SARS-CoV-2 , 2022, The New England journal of medicine.

[7]  R. Ismagilov,et al.  Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection , 2021, Journal of clinical microbiology.

[8]  R. Peeling,et al.  Diagnostics for COVID-19: moving from pandemic response to control , 2021, The Lancet.

[9]  T. O'Leary,et al.  Relative sensitivity of anterior nares and nasopharyngeal swabs for initial detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis , 2021, PloS one.

[10]  O. Pybus,et al.  Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool , 2021, Virus evolution.

[11]  G. Wallau,et al.  COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence , 2021, Nature Medicine.

[12]  M. Karyana,et al.  Review of Current COVID-19 Diagnostics and Opportunities for Further Development , 2021, Frontiers in Medicine.

[13]  R. Ismagilov,et al.  Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection , 2021, medRxiv.

[14]  M. Rodríguez-Pérez,et al.  Comparison Between a Standard and SalivaDirect RNA Extraction Protocol for Molecular Diagnosis of SARS-CoV-2 Using Nasopharyngeal Swab and Saliva Clinical Samples , 2021, Frontiers in Bioengineering and Biotechnology.

[15]  E. Diamandis,et al.  Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection , 2021, medRxiv.

[16]  Rose A. Lee,et al.  Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay , 2020, Journal of Clinical Microbiology.

[17]  R. Neher,et al.  Nextclade: clade assignment, mutation calling and quality control for viral genomes , 2021, J. Open Source Softw..

[18]  M. Bergevin,et al.  Efficient SARS-CoV-2 detection in unextracted oro-nasopharyngeal specimens by rRT-PCR with the Seegene Allplex™ 2019-nCoV assay , 2020, Virology journal.

[19]  Elizabeth B White,et al.  SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity , 2020, Med.

[20]  Paul-Christian Bürkner,et al.  brms: An R Package for Bayesian Multilevel Models Using Stan , 2017 .

[21]  Stefan Elbe,et al.  Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.

[22]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.